Amad, Cepriano B.
HRN: 16-84-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/14/2024
10/21/2024
IV
4.5g
Q8
Gastrointestinal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes